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Background: Human infection studies (HIS) involve deliberately 
infecting healthy volunteers with a pathogen in a controlled 
environment to understand infection and support the development of 
effective vaccines or treatments. HIS research is expanding to many 
low and middle-income settings to accelerate vaccine development. 
Given the implementation of the first HIS research to establish the 
experimental human pneumococcal carriage model’s feasibility, we 
sought to understand the participant’s opinions and experiences. 
Methods: We used a qualitative, descriptive approach to understand 
participants perceptions and experiences on HIS participation. Sixteen 
healthy adult participants were invited to participate in in-depth exit 
interviews to discuss their experiences, motivations and concerns. 
Results: Our findings showed that the likelihood of participation in HIS 
research rests on three essential conditions: motivation to participate, 
compensation and advocacy. The motivation and decision to 
participate was based on reasons including altruism, patriotism, 
monetary and material incentives, and while compensation was 
deemed appropriate, concerns about unanticipated research-related 
risks were raised. Participant advocate groups were recommended for 
increasing awareness and educating others in the broader community 
about HIS research. 
Conclusions: Participants’ experiences of HIS in Malawi provide the 
basis of what can be acceptable in HIS research in lower-income 
countries and areas where study procedures could be adjusted.
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Introduction
Human infection studies (HIS) or controlled human infection 
models (CHIM) involve deliberately infecting healthy adult 
volunteers with a pathogen in a controlled environment to bet-
ter understand infection and support the development of effective 
vaccines or treatments1. HIS have been conducted over hundreds 
of years and have contributed vital scientific knowledge leading 
to advances in the development of drugs and vaccines. Recently, 
HIS have received renewed interest, particularly in disease- 
endemic settings, because they offer an efficient and cost- 
effective approach for selecting the most promising vaccines for 
further development in populations that bear the more significant 
burden of infection2. HIS allows efficacy data to be generated 
quickly and promotes the identification of good immune correla-
tions, the down-selection of vaccine candidates and early vac-
cine formulation decisions, and therefore provide an opportunity 
to circumvent the large-scale field efficacy studies to deselect 
intervention candidates2,3.
HIS have been conducted in low and middle-income countries 
(LMICs) such as Columbia, Kenya, Tanzania and Thailand4, 
Gabon5, Equatorial Guinea, and Mali6. Plans to conduct HIS in 
other settings such as India7, Vietnam8, Uganda9, Malawi10, to 
name a few, are underway to explore the acceleration of vac-
cine development relevant to LMIC populations. While HIS offer 
scientific opportunities, there are some ethical issues concern-
ing HIS, especially in LMICs. Some of the concerns include 
aspects of research ethics, for instance, concerning benefit-sharing, 
limits to risk, the right to withdraw, informed consent, com-
pensation for participants, and research with children or other 
vulnerable participants, for example, pregnant women11. 
Other concerns relate to compensation, particularly if par-
ticipant exposure to risks or harm is perceived as high, and 
potential burdens of participation are perceived to be impactful12. 
Yet other concerns relate to issues of governance of HIS research, 
particularly in LMICs. The lack of specific ethical frameworks 
and guidelines for ethics committees raises issues about a lack 
of review procedures that will guide the evaluation of human 
infection research11. Despite the concerns, HIS offers poten-
tial opportunities to quickly identify and develop vaccines and 
provide them to those who need them.
Evidence on experiences and decision making among HIS 
participants remains limited, but a small number of articles have 
pointed to a range of motivations for taking part. Research with 
malaria HIS participants in Kenya found that monetary compen-
sation was a primary motivation6. In the US, alongside finan-
cial incentives, participants reported altruism, and experiential 
motivations, such as curiosity, as reasons for participating in 
CHIM research13. Beyond HIS, there is limited evidence on 
motivation among healthy research volunteers. Only a few stud-
ies have examined why they join research, how they evaluate 
risks, and how well they understand these risks14. A review of 
the literature on motivation among healthy volunteers across a 
range of clinical research studies (though almost all in high- 
income countries) found that participation was motivated by 
financial reward, contributing to science or the health of others, 
accessing ancillary healthcare benefits, interest in the science 
or goals of the study, meeting people and curiosity15. Exploring 
participants’ perceptions and experiences in LMICs is essential 
for understanding what is appropriate, acceptable and practically 
feasible to provide ethical guidance for the conduct of HIS 
research.
HIS in Malawi
The Malawi-Liverpool Wellcome Trust Clinical Research Pro-
gramme (MLW) has recently completed a feasibility study 
of experimental human pneumococcal carriage (EHPC) in 
Malawi16 under an umbrella programme titled: Malawi Acceler-
ated Research in Vaccines using Experimental and Laboratory 
Systems (MARVELS). MARVELS is a clinical research pro-
gramme conducting HIS for vaccine development – targeting both 
transmission and infection. The current research question that the 
MARVELS group of researchers seek to address is whether 
HIS can test the anti-pneumococcal vaccine in Malawi. Before 
implementing the feasibility study, the MARVELS group con-
ducted a formative qualitative study interviewing research 
staff, clinicians, district health officials, ethics committee mem-
bers, medical students, and community representatives from 
rural and urban Blantyre to gather views on the acceptability of 
HIS in Malawi. The study’s findings revealed that acceptability 
depended on various factors related to informed consent proce-
dures, inclusion criteria, medical care and support, compensation, 
regulation and robust community engagement. The interviewed 
stakeholders also expressed concerns about the safety of study 
volunteers and distrust or confrontation from community 
members if a participant were to become ill17. The findings 
informed the implementation of the pneumococcal feasibil-
ity study. In particular, information on stakeholder views helped 
MARVELS researchers understand how to design the study so 
that recruitment procedures addressed stakeholder concerns yet 
still maintained the scientific procedures based on an established 
pneumococcal carriage model from the Liverpool School of 
Tropical Medicine (LSTM), UK18.
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Aim of the study
Building on the formative qualitative study of stakeholder 
views, this study aimed to assess acceptability among the 
healthy adult volunteers who had completed the feasibility study, 
including their opinions on study recruitment and consent proce-
dures, medical care and support, compensation, and community 
engagement. This feedback from participants was sought to help 
identify areas where study design could be improved to ensure 
participants have a positive experience and maximise their 
comfort. These findings will help inform the design of a 
pneumococcal conjugate vaccine (PCV13) trial in Malawi 
similar to that carried out in the UK18.
Methods
Overview of the MARVELS pneumococcal feasibility study
In the MARVELS pneumococcal feasibility study, 24 healthy 
adult volunteers were inoculated with viable Streptococcus 
pneumoniae serotype 6B or 0.9% saline (sham inoculation) to the 
inside of each nostril. Blood, throat swabs, saliva, nasal scrapes, 
and nasal wash samples were obtained at days 2, 7, and 14 post- 
inoculation following the pneumococcal challenge and par-
ticipants were discharged from the study on day 21. Of the 24 
participants enrolled in the study, some participants received a 
dose between 20,000 or 80,000 bacterial colony-forming units to 
each nostril (naris) in 100 µl of saline. A pre-specified randomi-
sation list determined the randomisation of participants. Par-
ticipants were monitored for safety and the establishment of the 
pneumococcal carriage during their enrollment. Participants were 
provided with a thermometer and antibiotics following inocula-
tion. They were advised to monitor their temperature daily and 
report any signs and symptoms during the enrollment period. 
Any reported symptoms were characterised as mild, moderate 
or severe by the study doctor and treated according to a standard 
operating procedure. Participants were required to contact (text 
message/phone) a specified member of the research team before 
12:00 hours every day for seven days post-inoculation irrespec-
tive of whether they had experienced symptoms or not. Partici-
pants were provided with hotel accommodation for the first three 
nights. A field nurse was stationed at the hotel during all par-
ticipant overnight stays to monitor any adverse reactions that 
may have occurred within 24 hours of receiving the inoculum. 
Participants were then checked out from the hotel after their 
stay and reminded to return to the clinic on the scheduled visits. 
Participants received MWK 8,400 (~11 USD) per study visit as 
reimbursement for out-of-pocket expenses such as travel and 
compensating for time spent and burdens incurred while partici-
pating in the study. In total, participants received MWK 67,200 
(~91 USD). The compensation offered in this study was 
consistent with the remuneration guidelines published in 
Malawi19, paid pro-rata (per activity and not dependent on the 
completion of the study).
Recruitment
Before recruitment, enrolment and consent procedures for the 
feasibility study, the MLW Science Communication department 
organised the public engagement activity at the University of 
Malawi’s Polytechnic college through the Polytechnic dean 
of students office and the student’s union (PSU). The 
Polytechnic campus, approximately 3km from QECH. After the 
public engagement activity, interested participants were given 
contact information and invited to a one-on-one visit to the 
research clinic. There they were briefed about the research 
and study procedures, including their participation in an exit 
interview. They were provided with an opportunity to ask ques-
tions and seek further clarifications. During this information 
visit, the research team did not ask participants to consent to the 
interview on the spot to give them a cooling-off period to make a 
decision, and subsequent non-engagement was taken as a deci-
sion not to participate. These two processes (the public engage-
ment activity and the one-on-one research clinic informational 
visit) allowed participants to meet the research team, ask questions 
and have time for contemplation and reflection. These processes 
were designed to improve their understanding of the research 
and help their decision-making. It was only on the day of 
screening and enrolment that consent for participation was 
obtained16. 
Study site
Interviews for the qualitative study were conducted in a pri-
vate meeting room in the MLW research institution building. 
MLW is based in Blantyre and is situated adjacent to Queen 
Elizabeth Central Hospital (QECH). QECH is the largest 
government referral hospital in the country, with an official 
bed capacity of 1350. The hospital serves as the College of 
Medicine’s teaching and research hospital.
On their last scheduled study visit (day 21), we invited par-
ticipants to participate in an exit interview. Study participants 
consented to participate in the exit interviews in the MLW 
research institution building. The sample size was not defined 
because the MARVELS pneumococcal feasibility study was 
powered to recruit only 36 participants to establish carriage. 
By the time we experienced our first-wave of COVID-19 in 
April 2020, a total of 24 participants had completed the study. 
At that point, we interviewed 16 participants and observed 
through ongoing data analysis that no new information was being 
gathered or learned. At which point, we determined to have 
achieved saturation.
Biases within qualitative research are well-known, and 
although the exit interview was held on MLW premises, specific 
attention was given to avoid biases. In particular, attention was 
given to address interviewee biases knowing that interviewees 
may choose to withhold detailed descriptions or embellish 
them, mainly if the ‘truth’ is inconsistent with their preferred 
self-image, experience and opinion or wish to impress the 
interviewer20. To address this concern, the interviewers made 
sure to probe, seek clarification, and continually refer back to 
what the participant had said, mainly if there appeared to be 
contradictions. Attention was also given to reflexivity threats 
because while researchers wish to adopt a relatively neutral 
role, they may inadvertently demonstrate a preference for a 
particular perspective, and in the process, bias their findings20. 
To this end, the two main social science researchers (NT and 
LMT) worked independently from the clinical team with a clear 
objective for reporting on the participants’ ethical concerns and 
experiences and continually discussed and agreed on codes, 
categories, and themes.
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Interviews
We used a semi-structured exit interview-guide that was piloted 
and tested in March 2019. The interview-guide (Table 1) was 
piloted on two health workers to check for clarity, relevancy, 
comprehensiveness, and questions flow. Questions that we identi-
fied as ambiguous were amended. Two social science researchers 
Table 1. Participants Exit Interviews Topic Guide
Question Probe on the following
General views on 
the study
How did you hear about this study? Motivation to participation?
What made you decide to take part in this study?
What are your general experiences of participating in this 
kind of study
Anything that made you unsure about 
joining the study?
How does that compare to how you feel about it now?
Recruitment What do you think about our study participant recruitment 
approaches?
Access to target population, use of flyers?
What did you find the most important part of the 
recruitment process?
Participant information sheet? 
Opportunity to provide further details?
What other recruitment approaches need to be 
considered for similar studies in the future?
Screening and 
consenting
What can you tell me about your experiences with the 
screening procedures which was as part of checking your 
eligibility to participate in the study?
Sample collection procedures, screening 
questions, and HIV testing?





What can you tell me about your experiences with the 
procedures of being infected with the pneumococcal 
bacteria?
General feeling, fears, anticipated and 
anticipated symptoms and AEs, disease 
expectations, and laboratory results for the 
collected samples?
Did you have any thoughts on the risks of possible 
unexpected and (unconsented harm) from being infected 
with pneumococcal bacteria?
Harm to self, including possible harms to 
others and the environment?
Safety monitoring What symptoms did you experience during the study 
period?
What is your general overview of the safety monitoring 
processes put in place?
Whether the safety monitoring procedures 
put in place satisfactory?
Which approach worked for monitoring your safety? 
Calling and or SMS systems?
Was it enough? What need to be considered for future 
CHIM?
Follow-up visits – how convenient were they to you? Time, frequency of the visits in days, facilities, 
travel, sample collection procedures?
Were you given antibiotics to take at home? 
How important was it for you to have antibiotics at home? 
What need to be considered on the issue of antibiotics 
from your experience?
Information given on when to take the 
antibiotics?
Residential stay What do you think about your experience of staying at 
Grace Bandawe for 3 days during the study? 
Concerns, challenges, family or relations, 
work, or school demands? 
Effect on daily life experiences?
What if you stayed at home? Would you consider that 
important?
What would need to be considered to ensure the 
residential stay is okay for future CHIM studies in Malawi?
Accommodation, food, time?
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Question Probe on the following
Compensation What do you think about the money you received for 
being in this study? Does it seem like a fair amount? If 
yes, what makes it a fair amount? If no, what do you think 
would be a fair amount? What would make that amount 
fair?
Satisfactory, not enough, too much?
What else do you think need to be considered on 
participant compensation?
What other means of compensation does the research 
team need to consider including for future human 
infection challenge studies?
Final thoughts What impact did participating in this study have on quality 
of your life?
What are your unmet needs and opportunities of 
participating in this study?
Would you encourage others to participate in this kind of 
study?
Is there anything you feel could have been done better in 
this study?
Improvements in future CHIM studies?
(NT and LMT) from the MARVELS project conducted exit 
interviews together or separately. Most interviews were con-
ducted primarily in English, with one conducted in Chichewa, 
based on participant preferences. All interviews were conducted 
face-to-face. Interviews lasted about 60 minutes each, and the 
open-ended questions covered topics about reasons and decisions 
to participate, understanding of the purpose of the study, pro-
cedures and risks, views of information provision, satisfaction 
with study experiences, compensation and any social impacts on 
participation, for example, education, family or home environ-
ment. The semi-structured interview topics were developed based 
on common concerns about human challenge studies raised in 
ethics literature and the formative research by Kapumba et al.17.
Data analysis procedures
Interviews were audio-recorded and transcribed by NT. 
Transcripts were de-identified and uploaded onto REDCap 
version 10, a web-based application used to capture data in a 
secure environment so that research teams can collect and store 
highly sensitive information21 for data management and analysis. 
Data was coded systematically and manually by two researchers 
(NT and LMT) in Microsoft Word version 16. NT and LMT 
developed and iteratively refined the codebook beginning with 
a priori codes from the interview guide. We used the research 
questions to group the data and then look for similarities and dif-
ferences. We developed a hierarchical coding framework to ana-
lyze texts based on participants feelings, opinions and experi-
ences, with broader higher-order codes providing an overview and 
detailed lower order codes allowing for distinctions to be made 
within and between cases22. NT and LMT each coded tran-
scripts separately, discussed the codes, reconciled any discrepan-
cies, and then summarised each code’s content. The codes were 
sorted into themes. These summaries formed the basis of our 
thematic content analysis. We achieved saturation from the 
16 participants interviewed. No new codes occurred from the 
data, suggesting that no further or new information was being 
gathered or learned about the volunteers’ perceptions and 
experiences.
Ethical approval
The EHPC study, consent forms and interview guides were 
approved by the National Health Sciences Research Committee 
(NHSRC) ethics committee (protocol number 19/08/2246) and 
the Liverpool School of Tropical Medicine (LSTM) ethics com-
mittee (protocol number 19-017). We sought permission from the 
Blantyre District Health Office (DHO) and the Queen Elizabeth 
Central Hospital’s Hospital Director to conduct this study. Par-
ticipants were provided with an information sheet and verbal 
explanations, and they provided oral and written consent.
Results
We interviewed 16 participants that were recruited between 
December 2019 and March 2020. Of the 16 participants, 15 were 
interviewed after all study procedures and after the final study 
visit and one participant was interviewed on a subsequent date 
rescheduled for participant convenience. The sample of 
participants is displayed in Table 2.
As displayed in Table 2, most of our participants were male 
(n=11), and the remaining were female (n=5). Most were 3rd and 
4th-year university students, while 1 participant had completed 
their secondary school education (O-level equivalent). All par-
ticipants were 18 years or above, and all indicated that this was 
the first time they had ever participated in a clinical research 
study.
We present our findings under four main themes. First, we 
present participants’ decision making around participation in 
the pneumococcal feasibility study, including their views on 
the public engagement event at the Polytechnic campus and 
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Table 2. Study participant demographics.
Gender Age Year of study
Male 23 4th year of a degree programme
Male 25 4th year of a degree programme
Male 22 4th year of the degree programme
Male 20 1st year of a degree programme
Male 26 4th year of a degree programme
Female 18 2nd year of a degree programme
Male 23 3rd year of a degree programme
Male 24 3rd year of a degree programme
Male 26 4th year of a degree programme
Female 20 3rd year of a degree programme
Male 27 4th year of a degree programme
Male 25 4th year of a degree programme
Male 27 4th year of a degree programme
Female 20 3rd year of a degree programme
Male 22 Completed Form 4, Malawi School Certificate of Education (MSCE)
Female 24 3rd year of a degree programme
study consenting procedures described above in the recruitment 
procedures section, and motivations for participating. Second, we 
describe their experiences with study procedures and methods, 
including safety monitoring plans and the three-night hotel stay. 
Third, we discuss views on compensation. Finally, we present 
the participants’ suggestions for engagement and recruitment for 
future HIS.
Participants’ decision-making and motivations for 
participating in the EHPC feasibility study
Most participants informed us that they decided to join the study 
after attending a public engagement event organised by the 
MLW research team.
“…the very first time they came to school [the Polytechnic], 
they presented the study, but there were some areas, which 
I did not understand, and there were questions, which I could 
not ask in the presence of others, you could like to ask in 
person with the team doing the research. I had that time to 
ask, and they told me all the relevant information about what 
is it all about for the research. So that helped me, that was a 
good move that I had that ample time to speak out anything 
I was afraid of, and they could answer me.” (CHIM 1028)
Participants particularly liked the private setting at the research 
clinic, which enabled them to ask questions they would 
not have done in their peers’ presence after the public 
engagement event and before enrollment.
“Yeah, because maybe sometimes you can make a hasty 
decision that you want to participate in the research, 
in the study. However, after being given that information, 
it gives you time to reflect again if you want to participate 
in the study. So, I think it was essential because, after 
that, it shows that you want to do it” (CHIM 1135).
Since most of the volunteers were students studying at a 
university, it was common for them to use the Internet to inde-
pendently research the study. The participants informed us that 
they conducted Internet searches on the pneumococcal carriage 
model from the LSTM to understand the pneumococci bacteria 
they would be inoculated with and the inoculation procedures 
to assess the study risks.
“To know more about bacteria, I researched...I just 
Googled pneumococci, and the Internet explained what this 
bacteria, pneumococci was... They said that this is mostly 
or is mostly in kids, if I am not wrong. Those affected most 
are children or those whose immunity is low, like people 
with HIV and AIDS and the elderly whose immunity system 
is low that bacteria can affect them, not healthy adults... I 
wanted to know more about this study… It helped me to 
have confidence enough that I join the study.” (CHIM 1036)
One participant consulted their family in the process of decid-
ing to participate in the study. While the relatives did not offer 
a direct opinion, the participant felt that this was their tacit 
way of giving permission and reassurance that a sensible 
decision was being made.
“Maybe the part I can explain about, which made me 
reach the point of deciding to participate was, it was when 
I came to explain to my relatives at home after I gave 
them the form after they read it through, I felt to say: ah I 
think I can participate, there was a section where it 
explained to say: some people will get the bacteria while 
some will not” (CHIM 1184).
The motivation to participate was based on perceived individual 
benefits and societal value. As one participant put it,
“My interest is to focus much on research, so the most 
important reason is to participate and gain more knowledge” 
(CHIM 1069).
A couple of participants were motivated to participate as 
they were very keen to know their general health status, which 
included an HIV antigen test.
“Of course, just one part that you said before the experiment 
has to be carried, there was supposed to be a medical 
check-up, so, that was also some motivation to me, to know 
myself about my body” (CHIM 1085).
“I was so motivated when they said we would have your 
health check-up. In most cases, I have been looking for that, 
but then if you look at the money going to the hospital and 
then having the check-up, it would cost me a lot. So, I was 
partly motivated because of that that I should know how 
I am. Even though the study did not have that fully checking 
up of the entire body, you had just some special areas 
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that you were supposed to look at, but still more it has been 
good” (CHIM1119).
Only one participant mentioned money as the primary 
motivating factor for participating in the EHPC study.
“Besides money [laughs], but otherwise no, I just wanted 
to take part… Anyway, okay, generally, money is a basic 
need, it is a necessity, so with sixty-seven thousand, it 
was at least an attractive package” (CHIM1010).
The social value of participating in the research was expressed 
in the form of altruism and patriotism. Almost all participants 
spoke of the desire to help humanity and Malawians impacted 
by pneumonia and the scientific community develop a better 
vaccine.
“I just felt like at least I should be one of the people that 
could contribute to something good to the entire nation 
because I know this could be. It is something that has been 
recommended in Malawi. Therefore, it would carry a certain 
value. So, I thought of being part of it” (CHIM 1119)
Patriotism, expressed in the form of self-sacrifice or selfless-
ness, was articulated when one participant described himself as 
a “risk-taker”.
“Ah, here I can say that I had no worry considering that I am 
a risk-taker. So joining it was just like that. I think I made 
up my general mind that I am joining this, and if they are 
telling me that this is the way it is handled. You will experience 
this and that, and nothing else can harm me as they said 
that it worked 100% in Liverpool. I was, like ah. I think this 
is just okay after so my first days when I experienced nothing, 
I did not have a fear that anything can happen” (CHIM 
1028)
While this participant expressed the view that he was a 
“risk-taker”, his motivation and ultimate decision to participate 
were balanced by assessing the risks and the potential benefits.
“My interest was that I would be the one involved in 
helping the community because I know that when a vaccine 
is found, and I was involved in the process of making the 
vaccine, you will be reaching to many people that I cannot 
personally reach” (CHIM 1028).
Experiences with study procedures and methods
Participants described positive and negative aspects of the 
study procedures. Positive factors included staff attitudes, 
safety monitoring and support for health care. 
Several participants commented on the research staff’s 
friendly nature, which helped participants feel comfortable 
with the study follow-up visits and clinical procedures.
“The nurses were friendly, the way they talked to us, the 
way they were handling us, it was just okay, and I could 
feel that sense of closeness, sure. I think, for me, I can say 
it was just okay, because even they were flexible may be 
telling them that we will meet at such a time or that maybe 
you have changed time due to some changes, they would 
understand. I think it is just okay” (CHIM, 1028).
Participants also appreciated the safety monitoring proce-
dures, including the hotel’s accommodation for three nights 
immediately after receiving the inoculum. The Grace Bandawe 
Conference Centre [GBCC] is situated 3.4 km (four-minute 
drive) from a private medical facility (Mwaiwathu Private 
Hospital) to provide study participants with medical care should 
they experience a severe adverse event.
“My experience was great. Yeah, everything about food, 
the place that we were sleeping, and it was a comfortable 
place and a very conducive environment for research like 
this” (CHIM 1085).
“You provided a person with all the options which he 
or she can follow if at all is feeling unwell. For example, 
you have given us an allowance, let’s find somebody gets 
sick while he is maybe somewhere very far, so he could 
travel using that money to go to the hospital. You also gave 
us a card whereby you can go to the Mwaiwathu hospital 
at any time where we were feeling unwell. The third was 
being accommodated at Grace Bandawe, which is very close 
to the Mwaiwathu hospital. Now, that thing itself is very 
good and has caused my experience to be excellent as well” 
(CHIM 1143).
Participants also appreciated receiving other forms of imme-
diate medical care and support as part of the study safety 
monitoring. This included being escorted by a nurse/fieldworker 
for the nights spent at the hotel, the ability to access the medi-
cal team at all hours via cellphone, and a safety information 
sheet listing possible side-effects, such as a temperature of 
>37.5°C, shivering, headache, new rash, drowsiness, cough, ear-
ache, and or new eye infection. Participants were also provided 
with a thermometer to monitor their temperature personally and 
provided antibiotics to take if their temperature was too high.
Because having a thermometer that’s, because one of 
the symptoms of you know these bacteria is a rise in 
body temperature. So, having that in mind, I think that is 
enough. Furthermore, that card, like the information sheet, 
was good. There were just so many points that you cannot 
miss out on them, you see, maybe you are feeling something, 
it was listed on the card, so, that was enough for me” 
(CHIM 1010).
There were mixed views on the actual inoculation procedures. 
Most participants expressed initial feelings of fear and apprehen-
sion about receiving the inoculum.
“At first, I was very afraid. Actually, I was so afraid of, 
okay, I that running nose, that’s exactly one thing that 
I hate the most. I fail to study when I have a runny nose, 
so I hate it a lot” (CHIM 1093).
A couple of participants did note feeling unwell after 
receiving the inoculum. One of them reported having a runny 
nose, and another reported experiencing fatigue.
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“I had a runny nose, that’s exactly one thing that I hate the 
most. I fail to study when I have a runny nose, so I hate 
it a lot” (CHIM 1093).
“Somehow I was feeling like just tired, somehow a little 
headache and that general feeling that I am not well, 
but I cannot explain it the way it was, but just feeling that 
I am not okay” (CHIM 1051).
Other concerns about inoculation related to the potential 
harm that the bacteria can cause to others.
“Yes, you know the social world we live in we always 
associate with people. So whenever you are with a friend 
you have met, certain family and they have a kid, you feel 
like carrying the kid, but when you think of oh, I am going 
under this, so you are somehow refraining, avoiding meeting 
people, avoiding going to family members, like family 
friends to chat, like there are kids there they will need me 
to carry. I have a sister, and she has a kid and that day, the 
kid was seven months old, so I never held her. It was just 
like I was avoiding her (CHIM 1093).
But many also talked about feeling reassured because of the 
antibiotics the study provided, the independent research they 
had done before joining the study and the fact they did not 
experience any untoward event.
“I was nervous. A bacteria is a bacteria; it is a microorganism. 
Sometimes it can decide to misbehave. There can be 
something that would alter the body, like the chemical reactions 
and the likes, so, I was afraid, of course, I was nervous. 
However, I knew, like from education-wise, we know what 
bacteria do, and there are treatments for bacteria. Yea, so, if 
anything, then take the antibiotics” (CHIM 1010).
Despite the worries, one study participant reported feeling 
at ease with receiving the inoculum.
“My experience to say that after inoculation as I said 
at first that I was like somehow worried but in the process, 
it was found that the worry disappeared because I did not 
experience anything unusual or that I was feeling sick. 
I was just okay the way I was even before joining the 
research. Hence I had the confidence that aah, I think these 
things are all right because the way they explained before the 
research that there is nothing harmful that can happen after 
inoculation, after being inoculated the bacteria there was 
like no harm that happened in line with what they said” 
(CHIM 1028).
Participants were also asked about their experiences with sam-
ple procedures, including the throat swab, nasal scraps, nasal 
washes, blood and saliva samples. Most participants were 
comfortable having their blood and saliva samples taken. 
However, many found the nasal scrapes, nasal washes and throat 
swabbing procedures uncomfortable. Holding water in the 
nose and then expelling it created discomfort. Similarly, hav-
ing a throat swab sample taken was awkward because of the gag 
reflex.
Compensation
Questions regarding the appropriate compensation levels for 
HIS research in Malawi required evaluation. Participant views 
on the monetary payments they received varied. Some par-
ticipants felt that the amount of compensation provided was 
reasonable.
“The study was not that demanding, and comparing the 
risk and the compensation that we are getting, it is fair, yes. 
So, the study was not demanding that much, and the clinic 
was just in a convenient place. It was easy to get to the 
clinic. So, mainly I would say the compensation was main-
ly for the airtime and the transport I would use to get to 
the clinic” (CHIM 1150)
However, others felt the compensation was inadequate compared to 
the perceived health issues that might appear after study participa-
tion is complete.
“What we are dealing with here is the human health of 
which if somebody has been inoculated with that bacteria, 
we never know some further reactions in their bodies that 
could happen even after the study maybe one year after 
now or two years from now. You know some things may 
happen after a very long period. Maybe this will have an 
adverse effect in the future. We never know. So, if we are to 
look at the health status of that participant, then the money is 
not enough” (CHIM 1119).
“Personally, it would have been difficult for me to say 
the amount because, to me, I do not take money as 
something that you can consider to be compensated with 
because I do not think money can compensate you if 
something goes wrong” (CHIM 1051).
Another participant believed that monetary compensation for 
research burdens could not be equated with the value of life. 
Therefore, money would not be able to compensate for the 
loss of life.
“It is just a little money… I told you that it is about health 
hazard when you are making a decision you are sure 
that you are putting your life at risk, you never know 
what may come out of the study” (CHIM 1127).
Apart from monetary compensation, participants were asked 
to reflect on what other payment forms would be suitable to 
offer in HIS. One notable view was to provide participants 
with health insurance to help compensate an individual should 
they fall ill during and long after the study is completed. Other 
ideas suggested were to offer participants risk allowances to 
cover unexpected and unpredicted costs, t-shirts and certificates 
of appreciation to acknowledge their role and contribution to 
research.
Suggestions for engagement and recruitment in future 
HIS research in Malawi
Participants in the study offered a mixture of suggestions 
on using community and public engagement platforms to 
communicate and promote understanding about HIS research, 
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particularly if future studies plan to recruit individuals from 
the broader community who are not as educated or literate as 
university students. Key among the suggestions offered were 
participant advocates in the public and community engage-
ment activities to provide first-hand testimonials about their 
experiences in participating in HIS research.
“For them to understand, they need people who have 
participated in this study, not just telling them that you have 
to do this but the experienced one” (CHIM 1127).
Another participant echoed the above sentiment and explained 
how involving former participants as advocates would help 
dispel possible misconceptions about this type of research 
that deliberately infects an individual with a disease-causing 
agent.
“some people might have misconceptions about the study. 
So, to hear from somebody who has gone through the 
study, their experience might be a bit more, how I can put 
this? They might feel a bit more reassured that somebody 
who is like me in some sort went through the study and 
is testifying. I can put it that way that the study is not as 
bad as I think it is or it is not what I think that the study 
is all about. So, to say for participant advocacy groups 
are very important” (CHIM 1150).
Social media platforms such as WhatsApp was also proposed 
as a more effective way to reach people.
“I feel like the approach is good, but maybe you can also 
employ social media, especially WhatsApp, because 
nowadays people are so active on WhatsApp. Sometimes 
just posting posters around, most people do not like looking 
at posters around, maybe with our generation. However, 
when something circulates on WhatsApp, it is easy to reach 
people. So, maybe you can include the spreading of the 
message using WhatsApp” (CHIM 1135).
Other recommendations included offering study participants 
full-time residency for the entire study period and home vis-
its as another way to bolster HIS safety and monitoring 
procedures.
Discussion
This is the first study in Malawi to examine participants’ per-
ceptions and experiences of participating in a HIS. Participants 
reported initial fears and concerns before they enrolled but 
that their anxiety levels dissipated after inoculation, primarily 
because of the strong communication with the nursing team and 
assurances by the study safety monitoring procedures, includ-
ing a three-night residential stay at the GBCC after inocula-
tion. From this, we can infer that HIS research is acceptable in 
Malawi. However, the likelihood of participation in HIS research 
rests on three essential conditions: motivation to participate, 
compensation and advocacy. In this section, we compare our 
findings to existing literature and map out recommendations 
for future studies.
Our findings on the factors influencing the decision and 
motivation to participate in the study included altruism, patri-
otism, financial benefits and medical health checks. This mir-
rors previously reported results in Malawi, where access to 
health care, monetary and material incentives given were the 
main reported reasons for participation in biomedical research23,24. 
Furthermore, the decision to participate was also influenced 
by the methods used for recruitment. The public engagement 
event held at the Polytechnic college, where the Liverpool 
EHPC research was presented and demonstrated to be safe, 
helped establish integrity and trust. Moreover, the research 
team’s attitude, which was described as friendly and flexible 
during screening and enrolment, further helped influence partici-
pants’ decisions to participate because they gained trust in the research 
team.
However, these views and experiences, which informed decisions 
to participate, can be partly attributed to cognitive dissonance 
theory. Cognitive dissonance suggests that individuals tend 
to seek consistency among their cognitions (i.e., beliefs and 
opinions) that can influence behaviours and actions25. In turn, 
these beliefs and views can help consolidate the perception that 
researchers have their best interests at heart26. Thus, this kind of 
reasoned behaviour must be approached with some degree of 
caution, particularly for the future of HIS research in Malawi, 
as it relates to evaluating whether participants are making an 
informed decision to participate in research.
While financial compensation for participation in research 
was a motivational factor, for the most part, our findings show 
that the notions of altruism, patriotism, perceived individual 
benefits, societal value, and volunteerism were primary reasons. 
Altruism, patriotism, and volunteerism were important aspects 
of achieving informed consent. This showed us that participants 
appreciated the risks, benefits and burdens. The issue of risk- 
allowances and health insurance pointed to participants’ con-
cern about how researchers would take care of unforeseen or 
unanticipated research-related illnesses. Similar problems 
were noted in a study done in India that reported on public per-
ceptions of HIS27. The study paid for no-fault insurance for 
participants to compensate for those who would sustain research-
related injuries. This is a regulatory requirement for high-risk 
research in Malawi. No-fault insurance for clinical trial research 
is a regulatory requirement that aims to assert the legal notion 
of responsibility in research and reflect the ethical thinking of 
solidarity to remind public health researchers in LMICs like 
Malawi that “an injury to one is an injury to all”28. Besides, the 
duty of care is a universal moral obligation for research, especially 
in HIS, where the possibility to cause harm could have severe 
legal and financially costly implications. Providing participants 
with clinical trial insurance, health insurance, and risk-allowances 
can be interpreted as the researcher and participant working 
together to share the risks and burdens inherent in HIS research.
Participant advocate groups (PAGs) for HIS in Malawi could be 
an essential tool for community and public engagement. This 
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study’s findings highlight an opportunity to establish PAGs to 
help researchers conduct HIS with public awareness. PAG 
members would comprise previous research participants who 
volunteer their time, knowledge and experience in participat-
ing in research. Their role would not be to convince people to 
join in HIS or facilitate recruitment, but rather to learn about the 
public’s fears, concerns and expectations29 and to respond to the 
questions and concerns that communities and the general pub-
lic may raise, ideally before the implementation of the study 
and their participation. PAGs, because of their experience, would 
help dispel misconceptions, increase awareness of health and 
medical research and improve engagement between researchers 
and the public30. Moreover, PAGs could be a means to 
engender the ethical conduct of HIS research further. Like com-
munity advisory groups (CAGs), PAGs would also be the 
eyes and ears of researchers and the community and31, in so 
doing, be able to protect the public’s interest and help them gain 
trust in the research process30.
Our study has some limitations, and the main one is that the par-
ticipants were interviewed at the clinical research institution 
after exiting the study. This may have affected openness 
because of the perceived links between the interviewers and the 
research team. Also, because we only collected the participant’s 
opinions and experiences, we may have ignored others’ views; 
for a more rounded assessment on the experiences, additional 
insights on experiences and acceptability with frontline research 
staff would have been helpful. Wider opinions from family 
members would also be necessary for understanding accept-
ability beyond immediate participants’ views. This would have 
given us a better understanding of informed consent, accept-
able levels of risk and compensation. A varied view of perspec-
tives and experiences in implementing and participating in HIS 
research will help deepen our understanding of acceptability in 
Malawi and contribute to the growing discourse and literature 
on the ethically acceptable approaches to HIS, and develop ethi-
cal frameworks, guidelines and principles on how to conduct 
HIS in LMICs.
Conclusion
Though participants were, at first afraid of participating in the 
first HIS human pneumococcal carriage research, participants’ 
experiences of HIS in Malawi provide the basis of what can 
be acceptable and areas where study procedures could be 
adjusted. MARVELS will use these to design the next steps of 
their research. Additionally, findings will also inform regulatory 
thinking on guidelines, frameworks and principles on how ethics 




The data generated and analysed are not publicly available 
because consent was not obtained for these to be made pub-
lic even if anonymized but are available from the corresponding 
author on reasonable request. Email address: ntoto@mlw.mw.
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Thank you for the opportunity to review this manuscript. This is clear and well written, 
contributing to the growing field of knowledge about the conduct of CHIM in LMICs. 
 
Introduction: 
It would be beneficial to define from the start the study population not only as healthy adult 
volunteers but as students. I assume the literacy level but potentially also the socio-demographic 
status of these students might not be fully representative for the population in Malawi. 
 
Paragraph 2, In the text: '...there are ethical issues concerning HIS, especially in LMICs' Some 
authors argue the ethical issues are not very different across settings. See: Kaewkungwal J, Adams 
P, Sattabongkot J, Lie RK, Wendler D (2019) Conducting human challenge studies in LMICs: 
A survey of researchers and ethics committee members in Thailand. PLoS ONE 14(10): e0223619.1
 'results suggest that, in the view of important stakeholders in Thailand, the ethical issues raised by 
human challenge studies in LMICS do not differ significantly from the ethical issues raised by human 
challenge studies in high income countries'. I know this is contested but I would nuance this 
statement or provide further argumentation/references. 
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Interviews: 
The interview guide was piloted on two health workers. Again I assume health workers might have 
a better grasp of medical terminology or research terminology than the general population. Did 
you consider piloting this guide with the students? 
 
The interview guide mentions:'How does that compare to how you feel about it now?', "it" 
referring to decision making or general experiences? My main issue here is that the interviews are 
all exit interviews and that issues such as desirability or recall bias are not addressed. Most 
research shows a difference between initial worries and doubts about a study intervention and 
experiences after study completion where these feelings of worry fade away as the participants 
get more familiarized with the study staff and experience positive situations. Did you collect any 
data before the study start on initial feelings, questions? 
 
Experience with study procedures and methods. 
The quote about the runny nose is used twice, are there other quotes that you might use instead? 
 
Compensation: 
I would encourage the authors to refer to the literature around compensation for harm. The idea 
of compensation after study completion or to pay for insurance is interesting. Given the current 
debate around payment for harm versus payment for risk in CHIM, this is certainly worth 
elaborating on. See:   
Grimwade O, Savulescu J, Giubilini A, et al. 




The discussion mentions initial fears dissipating but again this is at study end and it would have 
been very interesting to have initial (pre-enrolment data) versus end of study data. 
Regarding wider opinions; not only family members etc... could give valuable input but were any 
screen-failures or students who refused to participate interviewed? 
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